Significance of experimental infarct size as an indicator of therapeutic efficacy in humans

Stroke. 2007 Sep;38(9):e89-90. doi: 10.1161/STROKEAHA.107.481853. Epub 2007 Aug 2.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Animals
  • Cerebral Infarction* / diagnosis
  • Cerebral Infarction* / pathology
  • Cerebral Infarction* / therapy
  • Humans
  • Nitric Oxide Synthase Type II / antagonists & inhibitors
  • Prognosis
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Tumor Necrosis Factor-alpha
  • Nitric Oxide Synthase Type II